DocSym
β
Searchsearch
Search
(D01.1) Carcinoma in situ: rectosigmoid junction
More details coming soon
112 913 in individuals diagnosis carcinoma in situ: rectosigmoid junction confirmed
3 597 deaths with diagnosis carcinoma in situ: rectosigmoid junction
3% mortality rate associated with the disease carcinoma in situ: rectosigmoid junction
Diagnosis carcinoma in situ: rectosigmoid junction is diagnosed Men are 9.90% more likely than Women
62 047
Men receive the diagnosis carcinoma in situ: rectosigmoid junction
860 (1.4 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
50 866
Women receive the diagnosis carcinoma in situ: rectosigmoid junction
2 737 (5.4 %)Died from this diagnosis.
Risk Group for the Disease carcinoma in situ: rectosigmoid junction - Men and Women aged 70-74
In Men diagnosis is most often set at age 20-94
Less common in men the disease occurs at Age 0-19, 95+Less common in women the disease occurs at Age 0-24, 95+
In Women diagnosis is most often set at age 0-1, 25-94
Disease Features carcinoma in situ: rectosigmoid junction
Absence or low individual and public risk
Carcinoma in situ: rectosigmoid junction - what does this mean
Carcinoma in situ at the rectosigmoid junction is a condition where abnormal cells are present in the lining of the rectum and sigmoid colon, but have not yet spread to the deeper layers of the colon wall or to other organs. it is the earliest form of colon cancer and is often found during routine screening tests.
What happens during the disease - carcinoma in situ: rectosigmoid junction
Carcinoma in situ of the rectosigmoid junction is a pre-cancerous condition caused by an accumulation of genetic mutations in the cells of the rectosigmoid junction. these mutations cause the cells to grow and divide uncontrollably, forming a mass of abnormal cells that can eventually become cancerous. risk factors for this condition include a history of smoking, excessive alcohol consumption, and exposure to certain environmental carcinogens. early detection and treatment is essential for successful management of this condition.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination
- Colonoscopy
- CT scan
- Biopsy
- Endoscopic ultrasound
- Magnetic resonance imaging (MRI)
- Positron emission tomography (PET) scan
Treatment and Medical Assistance
Main Goal: To treat Carcinoma in situ at the Rectosigmoid junction.
- Perform a colonoscopy to identify the location and size of the lesion.
- Perform a biopsy to confirm the diagnosis.
- Undergo a surgery to remove the lesion.
- Receive chemotherapy or radiation therapy to reduce the risk of recurrence.
- Participate in regular follow-up care to monitor for recurrence.
15 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Carcinoma in situ: rectosigmoid junction - Prevention
Carcinoma in situ of the rectosigmoid junction can be prevented by avoiding known risk factors such as smoking, excessive alcohol consumption, and a diet low in fruits and vegetables. regular screening and early detection of precancerous changes can also aid in the prevention of this type of cancer.